Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
IVVD is expected to report earnings to fall 92.86% to 0 cents per share on August 19
Q2'25
Est.
$-0.01
Q1'25
Missed
by $0.12
Q4'24
Beat
by $0.07
Q3'24
Missed
by $0.18
Q2'24
Missed
by $0.03
The last earnings report on May 15 showed earnings per share of -14 cents, missing the estimate of -1 cents. With 1.03M shares outstanding, the current market capitalization sits at 110.96M.